Jazz Pharmaceuticals ( (JAZZ) ) has provided an update.
Jazz Pharmaceuticals is set to relocate its operations in Palo Alto following a new lease agreement with Hudson Palo Alto Square, LLC. This move comes after securing a tenant to relet their current premises, allowing for an effective lease termination by mid-2025. This strategic shift ensures Jazz continues its U.S. operations smoothly across key locations.
For detailed information about JAZZ stock, go to TipRanks’ Stock Analysis page.
